Prevention of future development of diabetes in employees at public schools
Not Applicable
- Conditions
- IGT
- Registration Number
- JPRN-UMIN000017662
- Lead Sponsor
- Hokuriku Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
taking medications for diabetes, post gastrectomy state, taking anticancer drugs, taking stroids, or positive for the serum hepatitis markers.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie diabetes prevention in individuals with IGT through lifestyle interventions?
How does observational diabetes prevention in IGT populations compare to pharmacological therapies like metformin or GLP-1 agonists?
Which biomarkers correlate with successful diabetes prevention in IGT patients during long-term observational studies?
What adverse events are associated with diabetes prevention strategies in IGT cohorts, and how are they managed?
What combination therapies or novel compounds show promise for IGT management alongside lifestyle modifications?